Harris Associates
Harris Oakmark Concentrated Strategy
Jun 2025 → Jun 2025
Our archive holds 1 letter from this strategy, behind 3 investment theses and positions in 4 companies. Every quote below is copied verbatim from the letter it came from.
1 letter in a year · follow all of Harris Associates for every strategy.
What it bought and sold
We initiated the following position(s) during the pe- riod: • Charles River Labs is the world’s leading pro- vider of research models and other services for preclinical research and drug development.
This provided us the opportunity to buy shares in a leading software business that we view as having significant competitive ad- vantages.
Also held
Its investment theses
- Charles River LabsJun 2025Charles River Labs is a leading provider of preclinical research services with a strong competitive advantage, poised for growth despite current challenges, making it an attractive investment opportunity.
- ICON PLCJun 2025ICON PLC is a leading contract research organization that presents a buying opportunity due to its low earnings multiple and potential for recovery in biopharma R&D spending.
- SalesforceJun 2025Salesforce is a leading technology company transforming into a profitable, shareholder-focused enterprise with strong competitive advantages despite a recent stock decline.